Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review

Date: March 28, 2017
Pages: 68
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S2C4F75EC58EN
Leaflet:

Download PDF Leaflet

Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review
Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases. The company primarily sells its products through pharmaceutical wholesale distributors and large pharmacies, in both the US and Europe. The company operates along with its subsidiaries and representative offices in Europe, the Americas, Asia Pacific, South Africa and other countries. Shire is headquartered in Dublin, Ireland.

Shire Plc Key Recent Developments

Feb 16,2017: Shire Announces Full Year 2016 Results
Feb 14,2017: Shire to Highlight Advancements in Rare Genetic Diseases
Feb 07,2017: Shire Responds to US Federal Trade Commission Civil Action
Feb 01,2017: New data from Shire aim to help close the diagnosis and treatment gap for people with Hemophilia
Jan 13,2017: Shire Joins Illinois Biotechnology Innovation Organization as Leadership Sponsor and Adds Shannon Resetich to the Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Shire Plc - Key Facts
Shire Plc - Key Employees
Shire Plc - Key Employee Biographies
Shire Plc - Major Products and Services
Shire Plc - Pharmaceutical Pipeline Products Data
Shire Plc, Pipeline Products by Therapy Area
Shire Plc, Pipeline Products by Development Phase
Shire Plc - History
Shire Plc - Company Statement
Shire Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Shire Plc - Business Description
Shire Plc - Corporate Strategy
Shire Plc - SWOT Analysis
SWOT Analysis - Overview
Shire Plc - Strengths
Shire Plc - Weaknesses
Shire Plc - Opportunities
Shire Plc - Threats
Shire Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Shire Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Shire Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Shire Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 16, 2017: Shire Announces Full Year 2016 Results
Feb 14, 2017: Shire to Highlight Advancements in Rare Genetic Diseases
Feb 07, 2017: Shire Responds to US Federal Trade Commission Civil Action
Feb 01, 2017: New data from Shire aim to help close the diagnosis and treatment gap for people with Hemophilia
Jan 13, 2017: Shire Joins Illinois Biotechnology Innovation Organization as Leadership Sponsor and Adds Shannon Resetich to the Board
Jan 03, 2017: Shire Appoints Ian Clark as Non-Executive Director
Dec 06, 2016: Planning permission granted for new Shire manufacturing site in Ireland
Nov 22, 2016: Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass.
Nov 10, 2016: Shire’s Investor Day Showcases Strength of Rare Disease Pipeline and Commercial Portfolio
Nov 04, 2016: Broad Range of Research to be Presented at ASH 2016 Demonstrates Shire's Commitment to Addressing Unmet Needs for Patients with Rare Hematologic and Specialty Conditions

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Shire Plc, Key Facts
Shire Plc, Key Employees
Shire Plc, Key Employee Biographies
Shire Plc, Major Products and Services
Shire Plc, Number of Pipeline Products by Therapy Area
Shire Plc, Number of Pipeline Products by Therapy Area (Cont.1)
Shire Plc, Number of Pipeline Products by Development Stage
Shire Plc, History
Shire Plc, Other Locations
Shire Plc, Subsidiaries
Shire Plc, Key Competitors
Shire Plc, Ratios based on current share price
Shire Plc
Shire Plc (Cont.1)
Shire Plc, Interim Ratios
Shire Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Shire Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Shire Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Shire Plc, Pipeline Products by Therapy Area
Shire Plc, Pipeline Products by Development Phase
Shire Plc, Performance Chart (2012 - 2016)
Shire Plc, Ratio Charts
Shire Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Shire Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Supernus Pharmaceuticals Inc
Pfizer Inc
Novo Nordisk A/S
Novartis AG
JCR Pharmaceuticals Co Ltd
Ferring International Center SA
Eli Lilly and Company
Bayer AG
Actelion Ltd
Skip to top


Ask Your Question

Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: